# Hallmarks of Sublethal Endothelial Injury Are Differentially Induced by Cuminum cyminum Extracts with Distinct Phytochemical Profiles

**Authors:** Margarita L. Martinez-Fierro, Virginia Flores-Morales, Idalia Garza-Veloz

PMC · DOI: 10.3390/cimb48030255 · Current Issues in Molecular Biology · 2026-02-26

## TL;DR

Different Cuminum cyminum extracts affect human endothelial cells in various ways, with some causing injury-like effects even without killing the cells.

## Contribution

The study reveals that sublethal endothelial injury can be induced by C. cyminum extracts with distinct phytochemical profiles, emphasizing the need for functional testing in safety evaluations.

## Key findings

- Organic extracts (methanolic, acetonic, hexane) caused endothelial stress and injury-related responses.
- Aqueous extract enhanced endothelial migration and upregulated FGF2 and NOS2 without significant cytotoxicity.
- Extract composition strongly influences endothelial responses, including migration, gene expression, and morphology.

## Abstract

Cuminum cyminum (cumin) is widely used as a culinary spice and medicinal plant, yet its endothelial effects remain poorly defined, and viability-only toxicity tests may miss relevant changes. We evaluated whether four C. cyminum extracts (aqueous, methanolic, acetonic, hexane) induce sublethal endothelial injury (SEI), defined as preserved viability with functional, molecular, and morphological alterations. Human microvascular endothelial cells (HMEC-1) were exposed to increasing extract concentrations, and endothelial viability, migration, molecular responses, and cytomorphology were evaluated. Organic extracts (methanolic, acetonic, and hexane) induced endothelial stress and injury-related responses. Methanolic and acetonic extracts caused concentration- and time-dependent cytotoxicity, accompanied by reduced migration, stress-related gene modulation, and marked morphological damage, whereas the hexane extract induced pronounced cytomorphological disruption and strong NOS2 induction. In contrast, the aqueous extract exhibited minimal cytotoxicity and significantly enhanced endothelial migration, together with FGF2 upregulation and moderate NOS2 induction, consistent with a sublethal, pro-migratory phenotype. Overall, extract composition strongly influenced endothelial responses, demonstrating that SEI can occur in the absence of overt cytotoxicity and highlighting the need to incorporate functional endothelial endpoints into the safety evaluation of herbal and plant-derived extracts.

## Linked entities

- **Genes:** FGF2 (fibroblast growth factor 2) [NCBI Gene 2247], NOS2 (nitric oxide synthase 2) [NCBI Gene 4843]

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Nos3 (nitric oxide synthase 3) [NCBI Gene 24600] {aka eNos}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, SERPINA1 (serpin family A member 1) [NCBI Gene 5265] {aka A1A, A1AT, AAT, PI, PI1, PRO2275}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}
- **Diseases:** metastasis (MESH:D009362), SEI (MESH:D057772), cytotoxic injury (MESH:D014947), ulcers (MESH:D014456), headache (MESH:D006261), hoarseness (MESH:D006685), gastrointestinal disorders (MESH:D005767), atherosclerosis (MESH:D050197), dyspepsia (MESH:D004415), cytotoxic collapse (MESH:D001261), Cytotoxicity (MESH:D064420), cardiovascular diseases (MESH:D002318), OS (MESH:C567932), tumorigenic (MESH:D002471), hypoxia (MESH:D000860), eye diseases (MESH:D005128), cancer (MESH:D009369), sensory complaints (MESH:D009477), vascular dysfunction (MESH:D002561), hepatic alterations (MESH:D056486), conditions (MESH:D020763), Endothelial dysfunction (MESH:D014652), thrombosis (MESH:D013927), inflammation (MESH:D007249), diarrhea (MESH:D003967), jaundice (MESH:D007565), neurological (MESH:D009461), kidney and bladder stones (MESH:D007669), hypertension (MESH:D006973), necrotic (MESH:D009336), tract (MESH:D014570), cough (MESH:D003371)
- **Chemicals:** acetone (MESH:D000096), Phytosterols (MESH:D010840), fatty acids (MESH:D005227), ethanol (MESH:D000431), terpenes (MESH:D013729), glutamine (MESH:D005973), Ellagic acid (MESH:D004610), beta-sitosterol (MESH:C025473), mitomycin (MESH:D016685), streptomycin (MESH:D013307), caryophyllene oxide (MESH:C515179), hydrocortisone (MESH:D006854), squalene (MESH:D013185), Acetonic (-), aldehydes (MESH:D000447), methyl oleate (MESH:C005576), bromine (MESH:D001966), NO (MESH:D009569), Phenolic acids (MESH:C017616), antimony (MESH:D000965), amphotericin B (MESH:D000666), ketones (MESH:D007659), p-cymene (MESH:C007210), ethylenediaminetetraacetic acid (MESH:D004492), alpha-pinene (MESH:C005451), Hexane (MESH:D006586), lipid (MESH:D008055), formazan (MESH:D005562), Tannins (MESH:D013634), alcohols (MESH:D000438), prostacyclin (MESH:D011464), arsenic (MESH:D001151), triterpenes (MESH:D014315), penicillin (MESH:D010406), HE (MESH:D006371), apiol (MESH:C446539), DMSO (MESH:D004121), PBS (MESH:D007854), amino acids (MESH:D000596), 2,4-dinitrophenyl hydrazone (MESH:C001072), luteolin (MESH:D047311), Cuminaldehyde (MESH:C007165), 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MESH:C022616), limonene (MESH:D000077222), saponins (MESH:D012503), esters (MESH:D004952), monoterpenes (MESH:D039821), apigenin (MESH:D047310), rutin (MESH:D012431), MTT (MESH:C070243), gamma-terpinene (MESH:C018669), trypan blue (MESH:D014343), water (MESH:D014867), essential oil (MESH:D009822), sugars (MESH:D000073893), quercetin (MESH:D011794), silica gel (MESH:D058428), beta-pinene (MESH:C010789), stigmasterol (MESH:D013265), potassium permanganate (MESH:D011196)
- **Species:** Cuminum cyminum (cumin, species) [taxon 52462], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** HMEC-1 — Homo sapiens (Human), Transformed cell line (CVCL_0307), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), L929 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_AR58)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024819/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024819/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024819/full.md

---
Source: https://tomesphere.com/paper/PMC13024819